Home > News > Headline News > Archive

Click on title to read the full article.

FDA sets date to review Avastin again for breast cancer

February 26, 2011

By Kevin Grogan

Roche will get the chance to support continued use in the USA of its blockbuster Avastin as a treatment for breast cancer at the end of June.

Nexavar® plus capecitabine enters Phase III for breast cancer

February 24, 2011

Nexavar? (sorafenib) plus capecitabine tablets will enter Phase III for treatment of advanced breast cancer.

'Key' to cancer spread tested in mice

February 22, 2011

BBC News today reported on research that “prevented breast cancer spreading to other organs in mice by blocking a chemical”. The researchers reportedly said that their findings provided "a ‘fantastic drug target’ and were ‘highly likely’ to be used in a clinical setting”.

ASCO Revises Guideline on Bone Metastases in Breast Cancer

February 22, 2011

By Sherry Boschert

The American Society of Clinical Oncology has revised its guidelines on care of bone metastases in metastatic breast cancer to reflect expanded treatment options as well as concern about osteonecrosis of the jaw, a rare but serious side effect.

MicroRNA hinders enzyme that promotes breast cancer spread to the brain

February 10, 2011

A small piece of genetic material stops the activity of an enzyme known to promote the spread of breast tumors to the brain, said a group of researchers at Baylor College of Medicine (www.bcm.edu). “We have shown that the enzyme heparanase is an important mediator of brain metastasis (breast cancer spread to the brain),” said Dr. Dario Marchetti.

Sethi GS '10 researches spread of breast cancer

February 9, 2011

By Patience Haggin

Discoveries made in Nilay Sethi GS ’10’s doctoral student thesis elucidate the processes that cause the spread of breast cancer and may lead to more effective treatments.

Scientists Discover Mechanism Involved In Breast Cancer's Spread To Bone

February 6, 2011

By Medical News Today

In a discovery that may lead to a new treatment for breast cancer that has spread to the bone, a Princeton University research team has unraveled a mystery about how these tumors take root.

Susan G. Komen boss: Our Avastin position is unchanged

February 4, 2011

The Wall Street Journal originally reported Wednesday that the Susan G. Komen for the Cure organization stopped promoting the use of Avastin for metastatic HER2-negative breast cancer patients who haven't taken the drug previously.

Opinion: Battling Cancer, and FDA Bureaucrats

February 1, 2011

By Robert Goldberg

For some patients with advanced breast cancer, 2011 began with a harrowing close call: A federal contractor announced that Medicare would no longer pay for women in several states to receive treatment with the drug Avastin.